Microcarrier

3D Cell Culture Market Size and Share to Surpass USD 8.9 Billion by 2035 | Roots Analysis

Retrieved on: 
星期二, 一月 16, 2024
Biotron, Regenerative medicine, Research, Toxicology, Incidence, B cell, Extracellular matrix, Immortalised cell line, ECM, Tissue, Drug discovery, Zeiss, Tissue engineering, 3D, Drug development, FDA, Microcarrier, Growth, 3D printing

LONDON, Jan. 16, 2024 /PRNewswire/ -- 

Key Points: 
  • Also, the maintenance of 3D cell culture equipment is complex and requires specialized training or skilled personnel, which enhances the overall cost of installing 3D cell culture.
  • Despite the market restraints, the 3D cell culture market is growing exponentially due to the increasing trend of personalized medicine and ongoing technological advancements to enhance the reproducibility of 3D cell culture-based experiments.
  • Based on the scaffold format, the 3D cell culture market is dominated by scaffold-based format, capturing 46% of the market share by 2035.
  • Based on the key geographical region, North America will dominate the 3D cell culture market, capturing 39% of the overall market share by 2035.

Microcarrier Market Poised to Reach $3.43 Billion by 2030: Driving Advances in Biopharmaceuticals and Vaccine Production - ResearchAndMarkets.com

Retrieved on: 
星期四, 十月 19, 2023
Biotechnology, Pharmaceutical, Health, Media, Research, Regenerative medicine, Incidence, Microcarrier, Vaccine, Cell biology, Reagent, Research and development, Conditional sentence, Diabetes, Bioreactor, Rheumatoid arthritis, Tissue engineering, Cell, Downstream processing, Institute of Information Technology Advancement, Environment, Lead, Cancer, Consumables, Pharmaceutical industry, Veterinary medicine, Fine chemical, Growth

The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.

Key Points: 
  • The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.
  • The Microcarrier Market is experiencing significant growth, driven by the need to enhance vaccine production yields, reduce costs, and address a wide range of diseases.
  • These beads provide a flexible platform for cell attachment and growth, facilitating the production of biopharmaceuticals, vaccines, and cell-based therapies.
  • The United States stands out in the Microcarrier Market, known for its innovation and technological advancements.

Pharmaceutical and Biotechnology Companies Lead the Microcarrier Market with Innovation and R&D Investments

Retrieved on: 
星期一, 十月 16, 2023
Incidence, Reagent, Lead, Vaccine, Consumables, Regenerative medicine, Cell, Conditional sentence, Biotechnology, Bioreactor, Cancer, Diabetes, Rheumatoid arthritis, Tissue engineering, Institute of Information Technology Advancement, Environment, Research and development, Downstream processing, Research, Cell biology, Microcarrier, Media, Pharmaceutical industry, Veterinary medicine, Fine chemical, Growth

The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.

Key Points: 
  • The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.
  • Pharmaceutical and biotechnology companies lead the Microcarrier Market, relying extensively on microcarriers for various applications.
  • Continuous investments in research and development, along with innovation in microcarrier technology, further bolster the demand for microcarriers.
  • The United States stands out in the Microcarrier Market, known for its innovation and technological advancements.

Profuse Technology Unveils Revolutionary Advancements in 3D Cultivated Meat Growth

Retrieved on: 
星期二, 九月 26, 2023
Steps, Acceleration, Taste, Heart, 3D, Future, TEL, Growth, Microcarrier, Love Profusion, Meat, Environment, Information technology, Poultry farming, Agriculture

Profuse Technology's media supplements and growth protocols achieve an astounding 80% reduction in the duration of the muscle growth phase on 3D scaffolds to only 48 hours to drive a more sustainable and efficient future for meat production.

Key Points: 
  • Profuse Technology's media supplements and growth protocols achieve an astounding 80% reduction in the duration of the muscle growth phase on 3D scaffolds to only 48 hours to drive a more sustainable and efficient future for meat production.
  • What sets Profuse Technology apart is its unique capability to facilitate the production of fully mature muscle tissue in a 3D environment, closely mirroring conventionally farmed meat.
  • Profuse CEO Guy Nevo Michrowski said, "It is essential to recognize that the heart of meat production lies in muscle growth, as meat equals muscle.
  • Profuse Technology stands poised to revolutionize the future of meat production, enabling a scalable, sustainable and ethical pathway toward the future of meat cultivation.

Global 3D Cell Culture Markets 2022-2035: Scaffold Format, Products, Application Areas, Purpose - ResearchAndMarkets.com

Retrieved on: 
星期二, 六月 7, 2022
Health, Biotechnology, B cell, Microcarrier, Research, Classification, Initial public offering, 3D, Titanium-rich scaffold formation, Scaffolding, CEO, Partnership, Investment, Method, Growth, Review, Organoid, Perfusion, Toxicology, Industry, Drug discovery, Tissue engineering, Engineering, Regenerative medicine, Gel, 3D printing, Mobile phone, Management

The "3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
  • At present, more than 140 companies offer 3D cell culture systems in a variety of formats, including scaffold-based products, scaffold-free products and 3D bioreactors.
  • Moreover, there has been an increase in scientific literature on 3D cell culture systems and collaborations for 3D bioreactors and cell culture products.
  • Elaborate profiles of prominent players offering Scaffold-based, Scaffold-free cell culture systems and 3D bioreactors (shortlisted based on the number of products being offered) that are engaged in the development of 3D cell culture products.

Outlook on the Microcarrier Global Market to 2027 - Key Players Include Thermo Fisher Scientific, Merck, Eppendorf and Danaher Among Others - ResearchAndMarkets.com

Retrieved on: 
星期一, 五月 9, 2022
Health, Genetics, Other Science, Research, Science, Pharmaceutical, Biotechnology, COVID-19, US, Microcarrier, Cell, Prevalence, Use, WHO, Gene, Research report, Cancer, Incidence, American Society of Gene and Cell Therapy, Tissue engineering, Vaccine, Society, CAGR, Infection, Research, Renewable energy, Fine chemical, Pharmaceutical industry, Sales, Growth

The global microcarrier market is estimated to reach US$ 2.24 Billion by 2027, from S$ 1.48 Billion in 2021.

Key Points: 
  • The global microcarrier market is estimated to reach US$ 2.24 Billion by 2027, from S$ 1.48 Billion in 2021.
  • COVID-19 Is Anticipated to Have a Noteworthy Impact On the Microcarrier Market:
    In our report, we have closely observed the impact of COVID-19 on the global microcarrier market.
  • It is one of the influential factors propelling the microcarrier market in the North American region.
  • Product - Global Microcarriers Market have been covered from 2 viewpoints:
    Application - Global Microcarriers Market have been covered from 4 viewpoints:
    End Use - Global Microcarriers Market have been covered from 3 viewpoints:
    Region - Global Microcarriers Market have been covered from 4 viewpoints:

Global Microcarrier Market to 2030 - Featuring Thermo Fisher Scientific, Lonza and Eppendorf Among Others - ResearchAndMarkets.com

Retrieved on: 
星期四, 十月 14, 2021
Biotechnology, Pharmaceutical, Health, CAGR, Efficiency, Growth, Drug development, Forecasting, Bioreactor, Microcarrier, Research, Biotechnology, USD, COVID-19, Incubator, Coal, Fine chemical

The "Microcarrier Market - Market Size & Forecasting to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Microcarrier Market - Market Size & Forecasting to 2030" report has been added to ResearchAndMarkets.com's offering.
  • However, without the COVID-19 impact, global microcarrier market was estimated to be USD 1,373.9 million in 2021 and reach USD 2,818.5 million in 2030, at a CAGR of 8.3%, during the forecast period.
  • Technological advancement is another key factor that has been fueling the growth of the global microcarrier market.
  • How will market shares of the national markets change by 2030 and which nation will lead the market in 2030?

Eat Beyond Portfolio Company SingCell to License Technology from National University of Singapore

Retrieved on: 
星期二, 四月 6, 2021
Articles, Countries, Biotechnology, Cellular agriculture, Cultured meat, Meat, Microcarrier, Singapore

VANCOUVER, BC and SINGAPORE, April 6, 2021 /PRNewswire/ - April 6, 2021 Eat Beyond Global Holdings Inc. (CSE: EATS) (OTCPK: EATBF) (FSE: 988) ("Eat Beyond" or the "Company"), an investment issuer focused on the global plant-based and alternative food sector, is announcing that its portfolio company SingCell Tx Pte Ltd. ("SingCell") has entered into a technology development agreement with the National University of Singapore to evaluate and license its plant-based edible microcarriers technology.

Key Points: 
  • VANCOUVER, BC and SINGAPORE, April 6, 2021 /PRNewswire/ - April 6, 2021 Eat Beyond Global Holdings Inc. (CSE: EATS) (OTCPK: EATBF) (FSE: 988) ("Eat Beyond" or the "Company"), an investment issuer focused on the global plant-based and alternative food sector, is announcing that its portfolio company SingCell Tx Pte Ltd. ("SingCell") has entered into a technology development agreement with the National University of Singapore to evaluate and license its plant-based edible microcarriers technology.
  • "This technology is very complementary to SingCell's existing 3D cell culture technology, and soon we will be able to offer a more comprehensive bioprocessing scale-up solution to our clients."
  • "SingCell is focused on improving the feasibility of the cultured meat industry by focusing purely on the cost and scalability of the technology," said Eat Beyond CEO Patrick Morris.
  • SingCell is well positioned to leverage these programs to develop its technology and manufacturing infrastructure in Singapore.

Global Microcarrier Market Report 2021-2026: Opportunities in Rising Demand for 3D Culture, Rising MAB Production & Growing Research and Manufacturing in Emerging Economies

Retrieved on: 
星期二, 四月 6, 2021
Biotechnology, Microcarrier, Vaccine, Economic growth

The major factors driving the growth of the microcarriers market are rising demand for cell-based vaccines, technological advancements, and the availability of government funding and venture capital investments for cell and gene research.

Key Points: 
  • The major factors driving the growth of the microcarriers market are rising demand for cell-based vaccines, technological advancements, and the availability of government funding and venture capital investments for cell and gene research.
  • The growing preference for single-use technologies is an important trend and driver for the market.
  • However, the high cost of cell biology research and limitations in the production of high-density cell cultures are restraining market growth.
  • In this report, the microcarriers market has been segmented based on product, application, end-user, and region.

$2.9 Billion Microcarrier Market by Equipment, Consumables, Microcarrier, Application, End User - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
星期二, 三月 30, 2021
Biotechnology, Genetics, Health, Biotechnology, Microcarrier

The "Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period.
  • The growing preference for single-use technologies is an important trend and driver for the market.
  • However, the high cost of cell biology research and limitations in the production of high-density cell cultures are restraining market growth.